Do these urinalysis findings—microscopic hematuria, mild proteinuria, low urine pH, specific gravity 1.025, small bilirubin, and no nitrite or leukocyte esterase—indicate nephrolithiasis (kidney stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Could This Be Kidney Stones?

These urinalysis findings are consistent with kidney stones, but they are not specific enough to confirm nephrolithiasis as the sole diagnosis—you must evaluate for both urologic causes (including stones) and glomerular disease.

Initial Interpretation of the Urinalysis

The urinalysis shows several findings that require systematic evaluation:

  • Microscopic hematuria (1+ blood) is present and must be confirmed with microscopic examination showing ≥3 RBCs per high-power field before proceeding with extensive workup 1, 2
  • Mild proteinuria (1+ or 30 mg/dL) can occur with kidney stones but may also indicate glomerular disease, especially when combined with hematuria 2, 3
  • Low urine pH (5.5) is associated with uric acid stone formation, as acidic urine promotes uric acid crystallization 4
  • Specific gravity of 1.025 indicates concentrated urine, which increases the risk of stone formation due to supersaturation 4
  • Small bilirubin (1+) is an unusual finding that does not typically occur with simple nephrolithiasis and warrants further investigation 1
  • Negative nitrite and leukocyte esterase effectively rule out urinary tract infection as the primary cause 5

Why Kidney Stones Are Possible

Several features support nephrolithiasis:

  • Hematuria is the hallmark of kidney stones, occurring in the majority of patients with acute renal colic 1, 4
  • Low urine pH (5.5) strongly suggests uric acid stones, as uric acid becomes insoluble in acidic urine 4
  • Concentrated urine (SG 1.025) increases stone risk through supersaturation of stone-forming salts 4
  • Mild proteinuria can accompany stones due to tubular injury from stone passage 1

Critical Red Flags That Require Additional Evaluation

Do not assume this is simply kidney stones without ruling out other serious conditions:

  • The combination of hematuria and proteinuria most commonly indicates glomerular disease, particularly when proteinuria exceeds 1,000 mg per 24 hours or is accompanied by dysmorphic RBCs or red cell casts 2, 6
  • Bilirubin in urine is abnormal and does not occur with uncomplicated nephrolithiasis—this suggests possible hemolysis, liver disease, or biliary obstruction 1
  • You must confirm true microscopic hematuria with microscopic examination showing ≥3 RBCs/HPF on at least two of three properly collected specimens before initiating any workup 1, 7

Immediate Next Steps

1. Confirm True Hematuria and Assess Proteinuria

  • Order microscopic urinalysis to confirm ≥3 RBCs/HPF and examine for dysmorphic RBCs (>80% suggests glomerular origin) and red cell casts (pathognomonic for glomerular disease) 1, 2, 7
  • Obtain spot urine protein-to-creatinine ratio to quantify proteinuria accurately, as dipstick readings are unreliable—values >0.5 g/g strongly suggest renal parenchymal disease 2, 8
  • Measure serum creatinine to assess renal function 1

2. Distinguish Between Urologic (Stone) vs. Glomerular Causes

  • If >80% dysmorphic RBCs or red cell casts are present, refer to nephrology immediately as this indicates glomerular disease 1, 2, 6
  • If normal-shaped RBCs with minimal proteinuria, proceed with urologic evaluation for stones 1, 7
  • Tea-colored or cola-colored urine suggests glomerular disease, while bright red blood suggests lower urinary tract bleeding 7

3. Imaging for Stone Detection

  • Multiphasic CT urography is the preferred modality for detecting renal stones, masses, and urothelial abnormalities with 96% sensitivity and 99% specificity 7, 9
  • Renal ultrasound can detect large stones but misses 62% of ureteral stones and 25% of all urinary tract stones 7

4. Metabolic Stone Evaluation (If Stones Confirmed)

  • 24-hour urine collection for calcium, oxalate, phosphate, uric acid, citrate, sodium, and creatinine to identify metabolic abnormalities causing stone formation 1, 4
  • Hypercalciuria is the most common metabolic disorder associated with calcium stones 4

Common Pitfalls to Avoid

  • Never attribute proteinuria solely to hematuria without quantification—dipstick readings are misleading and must be confirmed with 24-hour collection or spot protein-to-creatinine ratio 2
  • Do not dismiss the combination of hematuria and proteinuria as benign—this strongly suggests underlying glomerular disease requiring nephrology evaluation 2, 6
  • Bilirubin in urine is not explained by kidney stones and requires investigation for hemolysis or hepatobiliary disease 1
  • False-positive proteinuria occurs in >50% of urinalyses with confounding factors including hematuria and high specific gravity—confirmatory testing with protein-to-creatinine ratio is essential 3

When to Refer to Nephrology

Immediate nephrology referral is indicated if:

  • Protein-to-creatinine ratio >0.5 g/g (or >500 mg/24 hours) 2
  • Dysmorphic RBCs >80% or presence of red cell casts 1, 2, 6
  • Elevated serum creatinine or declining renal function 2
  • Hypertension accompanying hematuria and proteinuria 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hematuria and Proteinuria Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Nephrolithiasis.

Primary care, 2008

Research

Pyuria and Urine Cultures in Patients with Acute Renal Colic.

The Journal of emergency medicine, 2016

Guideline

Hematuria Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation of Microscopic Hematuria in High-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate management for a 48-year-old woman with prediabetes (hemoglobin A1c 6.0%), mildly elevated LDL cholesterol, a possibly contaminated urine sample showing leukocyte esterase positivity, pyuria, bacteriuria, hematuria, microscopic hematuria, and borderline low mean corpuscular hemoglobin concentration?
How to manage a patient with mild proteinuria and ketonuria?
What is the management plan for a 29-year-old male with proteinuria (Albumin-to-Creatinine Ratio (ACR)) of 6.3 mg/mmol?
What is the next step in managing a 32-year-old man with hematuria (presence of red blood cells in urine), cellular casts, and significant proteinuria, who is taking Xarelto (rivaroxaban) for atrial fibrillation and has a normal renal ultrasound?
What is the significance of 0-3 white blood cells (WBC) in urinalysis?
What low‑density lipoprotein cholesterol (LDL‑C) target should be set for an adult with markedly elevated lipoprotein (a) (≥50 mg/dL) without established atherosclerotic cardiovascular disease, and how does the target change if the patient has ASCVD, familial hypercholesterolemia, diabetes with target organ damage, or another major risk factor?
How should painful oral ulcers be managed in an adult with DRESS caused by cefuroxime?
When should carvedilol (Coreg) be held in a patient with congestive heart failure—specifically regarding heart rate thresholds, blood pressure, symptomatic hypotension, low‑output signs, acute decompensation, or serious arrhythmias?
How is a pancreaticoduodenectomy (Whipple procedure) performed?
In an 18‑year‑old woman with chronic bilateral lower‑abdominal pain that worsens with menses, currently on combined oral contraceptives despite migraine with aura, what is the appropriate contraceptive choice and next management steps?
What is the best way to switch an elderly patient from venlafaxine (Effexor) 75 mg twice daily to citalopram (Celexa)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.